1 Study Coverage 1.1 Cefotaxime Sodium API Product Introduction 1.2 Market by Type 1.2.1 Global Cefotaxime Sodium API Market Size Growth Rate by Type 1.2.2 ChP 1.2.3 USP 1.2.4 EP 1.3 Market by Application 1.3.1 Global Cefotaxime Sodium API Market Size Growth Rate by Application 1.3.2 Single Injection 1.3.3 Compound Injection 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Cefotaxime Sodium API Market Size, Estimates and Forecasts 2.1.1 Global Cefotaxime Sodium API Revenue 2016-2027 2.1.2 Global Cefotaxime Sodium API Sales 2016-2027 2.2 Global Cefotaxime Sodium API, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Cefotaxime Sodium API Historical Market Size by Region (2016-2021) 2.3.1 Global Cefotaxime Sodium API Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Cefotaxime Sodium API Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Cefotaxime Sodium API Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Cefotaxime Sodium API Sales Forecast by Region (2022-2027) 2.4.2 Global Cefotaxime Sodium API Revenue Forecast by Region (2022-2027) 3 Global Cefotaxime Sodium API Competitor Landscape by Players 3.1 Global Top Cefotaxime Sodium API Manufacturers by Sales 3.1.1 Global Cefotaxime Sodium API Sales by Manufacturer (2016-2021) 3.1.2 Global Cefotaxime Sodium API Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Cefotaxime Sodium API Manufacturers by Revenue 3.2.1 Key Cefotaxime Sodium API Manufacturers Covered: Ranking by Revenue 3.2.2 Global Cefotaxime Sodium API Revenue by Manufacturers (2016-2021) 3.2.3 Global Cefotaxime Sodium API Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Cefotaxime Sodium API Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Cefotaxime Sodium API Revenue in 2020 3.2.6 Global Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Cefotaxime Sodium API Price by Manufacturers 3.4 Global Cefotaxime Sodium API Manufacturing Base Distribution, Product Types 3.4.1 Cefotaxime Sodium API Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Cefotaxime Sodium API Product Type 3.4.3 Date of International Manufacturers Enter into Cefotaxime Sodium API Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Cefotaxime Sodium API Market Size by Type (2016-2021) 4.1.1 Global Cefotaxime Sodium API Sales by Type (2016-2021) 4.1.2 Global Cefotaxime Sodium API Revenue by Type (2016-2021) 4.1.3 Cefotaxime Sodium API Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Cefotaxime Sodium API Market Size Forecast by Type (2022-2027) 4.2.1 Global Cefotaxime Sodium API Sales Forecast by Type (2022-2027) 4.2.2 Global Cefotaxime Sodium API Revenue Forecast by Type (2022-2027) 4.2.3 Cefotaxime Sodium API Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Cefotaxime Sodium API Market Size by Application (2016-2021) 5.1.1 Global Cefotaxime Sodium API Sales by Application (2016-2021) 5.1.2 Global Cefotaxime Sodium API Revenue by Application (2016-2021) 5.1.3 Cefotaxime Sodium API Price by Application (2016-2021) 5.2 Cefotaxime Sodium API Market Size Forecast by Application (2022-2027) 5.2.1 Global Cefotaxime Sodium API Sales Forecast by Application (2022-2027) 5.2.2 Global Cefotaxime Sodium API Revenue Forecast by Application (2022-2027) 5.2.3 Global Cefotaxime Sodium API Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Cefotaxime Sodium API Market Size YoY Growth 2016-2027 6.1.1 Japan Cefotaxime Sodium API Sales YoY Growth 2016-2027 6.1.2 Japan Cefotaxime Sodium API Revenue YoY Growth 2016-2027 6.1.3 Japan Cefotaxime Sodium API Market Share in Global Market 2016-2027 6.2 Japan Cefotaxime Sodium API Market Size by Players (International and Local Players) 6.2.1 Japan Top Cefotaxime Sodium API Players by Sales (2016-2021) 6.2.2 Japan Top Cefotaxime Sodium API Players by Revenue (2016-2021) 6.3 Japan Cefotaxime Sodium API Historic Market Review by Type (2016-2021) 6.3.1 Japan Cefotaxime Sodium API Sales Market Share by Type (2016-2021) 6.3.2 Japan Cefotaxime Sodium API Revenue Market Share by Type (2016-2021) 6.3.3 Japan Cefotaxime Sodium API Price by Type (2016-2021) 6.4 Japan Cefotaxime Sodium API Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Cefotaxime Sodium API Sales Forecast by Type (2022-2027) 6.4.2 Japan Cefotaxime Sodium API Revenue Forecast by Type (2022-2027) 6.4.3 Japan Cefotaxime Sodium API Price Forecast by Type (2022-2027) 6.5 Japan Cefotaxime Sodium API Historic Market Review by Application (2016-2021) 6.5.1 Japan Cefotaxime Sodium API Sales Market Share by Application (2016-2021) 6.5.2 Japan Cefotaxime Sodium API Revenue Market Share by Application (2016-2021) 6.5.3 Japan Cefotaxime Sodium API Price by Application (2016-2021) 6.6 Japan Cefotaxime Sodium API Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Cefotaxime Sodium API Sales Forecast by Application (2022-2027) 6.6.2 Japan Cefotaxime Sodium API Revenue Forecast by Application (2022-2027) 6.6.3 Japan Cefotaxime Sodium API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Cefotaxime Sodium API Market Size YoY Growth 2016-2027 7.2 North America Cefotaxime Sodium API Market Facts & Figures by Country 7.2.1 North America Cefotaxime Sodium API Sales by Country (2016-2021) 7.2.2 North America Cefotaxime Sodium API Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Cefotaxime Sodium API Market Size YoY Growth 2016-2027 8.2 Asia Pacific Cefotaxime Sodium API Market Facts & Figures by Region 8.2.1 Asia Pacific Cefotaxime Sodium API Sales by Region (2016-2021) 8.2.2 Asia Pacific Cefotaxime Sodium API Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Cefotaxime Sodium API Market Size YoY Growth 2016-2027 9.2 Europe Cefotaxime Sodium API Market Facts & Figures by Country 9.2.1 Europe Cefotaxime Sodium API Sales by Country (2016-2021) 9.2.2 Europe Cefotaxime Sodium API Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Cefotaxime Sodium API Market Size YoY Growth 2016-2027 10.2 Latin America Cefotaxime Sodium API Market Facts & Figures by Country 10.2.1 Latin America Cefotaxime Sodium API Sales by Country (2016-2021) 10.2.2 Latin America Cefotaxime Sodium API Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Cefotaxime Sodium API Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Cefotaxime Sodium API Market Facts & Figures by Country 11.2.1 Middle East and Africa Cefotaxime Sodium API Sales by Country (2016-2021) 11.2.2 Middle East and Africa Cefotaxime Sodium API Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 REYOUNG 12.1.1 REYOUNG Corporation Information 12.1.2 REYOUNG Description and Business Overview 12.1.3 REYOUNG Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.1.4 REYOUNG Cefotaxime Sodium API Products Offered 12.1.5 REYOUNG Recent Development 12.2 Nectar Lifesciences 12.2.1 Nectar Lifesciences Corporation Information 12.2.2 Nectar Lifesciences Description and Business Overview 12.2.3 Nectar Lifesciences Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Nectar Lifesciences Cefotaxime Sodium API Products Offered 12.2.5 Nectar Lifesciences Recent Development 12.3 Medya Pharma 12.3.1 Medya Pharma Corporation Information 12.3.2 Medya Pharma Description and Business Overview 12.3.3 Medya Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Medya Pharma Cefotaxime Sodium API Products Offered 12.3.5 Medya Pharma Recent Development 12.4 Sandoz 12.4.1 Sandoz Corporation Information 12.4.2 Sandoz Description and Business Overview 12.4.3 Sandoz Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Sandoz Cefotaxime Sodium API Products Offered 12.4.5 Sandoz Recent Development 12.5 Kelun 12.5.1 Kelun Corporation Information 12.5.2 Kelun Description and Business Overview 12.5.3 Kelun Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Kelun Cefotaxime Sodium API Products Offered 12.5.5 Kelun Recent Development 12.6 NCPC 12.6.1 NCPC Corporation Information 12.6.2 NCPC Description and Business Overview 12.6.3 NCPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.6.4 NCPC Cefotaxime Sodium API Products Offered 12.6.5 NCPC Recent Development 12.7 Aurobindo Pharma 12.7.1 Aurobindo Pharma Corporation Information 12.7.2 Aurobindo Pharma Description and Business Overview 12.7.3 Aurobindo Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Aurobindo Pharma Cefotaxime Sodium API Products Offered 12.7.5 Aurobindo Pharma Recent Development 12.8 United Laboratories 12.8.1 United Laboratories Corporation Information 12.8.2 United Laboratories Description and Business Overview 12.8.3 United Laboratories Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.8.4 United Laboratories Cefotaxime Sodium API Products Offered 12.8.5 United Laboratories Recent Development 12.9 Orchid Pharma 12.9.1 Orchid Pharma Corporation Information 12.9.2 Orchid Pharma Description and Business Overview 12.9.3 Orchid Pharma Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Orchid Pharma Cefotaxime Sodium API Products Offered 12.9.5 Orchid Pharma Recent Development 12.10 CSPC 12.10.1 CSPC Corporation Information 12.10.2 CSPC Description and Business Overview 12.10.3 CSPC Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.10.4 CSPC Cefotaxime Sodium API Products Offered 12.10.5 CSPC Recent Development 12.11 REYOUNG 12.11.1 REYOUNG Corporation Information 12.11.2 REYOUNG Description and Business Overview 12.11.3 REYOUNG Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.11.4 REYOUNG Cefotaxime Sodium API Products Offered 12.11.5 REYOUNG Recent Development 12.12 Covalent 12.12.1 Covalent Corporation Information 12.12.2 Covalent Description and Business Overview 12.12.3 Covalent Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Covalent Products Offered 12.12.5 Covalent Recent Development 12.13 ACS Dobfar 12.13.1 ACS Dobfar Corporation Information 12.13.2 ACS Dobfar Description and Business Overview 12.13.3 ACS Dobfar Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.13.4 ACS Dobfar Products Offered 12.13.5 ACS Dobfar Recent Development 12.14 Dawnrays 12.14.1 Dawnrays Corporation Information 12.14.2 Dawnrays Description and Business Overview 12.14.3 Dawnrays Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Dawnrays Products Offered 12.14.5 Dawnrays Recent Development 12.15 Sterile India 12.15.1 Sterile India Corporation Information 12.15.2 Sterile India Description and Business Overview 12.15.3 Sterile India Cefotaxime Sodium API Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Sterile India Products Offered 12.15.5 Sterile India Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Cefotaxime Sodium API Industry Trends 13.2 Cefotaxime Sodium API Market Drivers 13.3 Cefotaxime Sodium API Market Challenges 13.4 Cefotaxime Sodium API Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Cefotaxime Sodium API Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Cefotaxime Sodium API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of ChP Table 3. Major Manufacturers of USP Table 4. Major Manufacturers of EP Table 5. Global Cefotaxime Sodium API Market Size Growth Rate by Application (2021-2027) & (MT) Table 6. Global Cefotaxime Sodium API Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Cefotaxime Sodium API Sales by Regions (2016-2021) & (MT) Table 8. Global Cefotaxime Sodium API Sales Market Share by Regions (2016-2021) Table 9. Global Cefotaxime Sodium API Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Cefotaxime Sodium API Sales Forecast by Region (2022-2027) & (MT) Table 11. Global Cefotaxime Sodium API Sales Market Share Forecast by Region (2022-2027) Table 12. Global Cefotaxime Sodium API Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Cefotaxime Sodium API Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Cefotaxime Sodium API Sales by Manufacturers (2016-2021) (MT) Table 15. Global Cefotaxime Sodium API Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Cefotaxime Sodium API Manufacturers by Revenue (US$ Million) in 2020 Table 17. Cefotaxime Sodium API Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Cefotaxime Sodium API Revenue Share by Manufacturers (2016-2021) Table 19. Global Cefotaxime Sodium API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Cefotaxime Sodium API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cefotaxime Sodium API as of 2020) Table 21. Key Manufacturers Cefotaxime Sodium API Price (2016-2021) (USD/MT) Table 22. Cefotaxime Sodium API Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Cefotaxime Sodium API Product Type Table 24. Date of International Manufacturers Enter into Cefotaxime Sodium API Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Cefotaxime Sodium API Sales by Type (2016-2021) (MT) Table 27. Global Cefotaxime Sodium API Sales Share by Type (2016-2021) Table 28. Global Cefotaxime Sodium API Revenue by Type (2016-2021) (US$ Million) Table 29. Global Cefotaxime Sodium API Revenue Share by Type (2016-2021) Table 30. Cefotaxime Sodium API Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 31. Global Cefotaxime Sodium API Sales Forecast by Type (2022-2027) & (MT) Table 32. Global Cefotaxime Sodium API Sales Market Share Forecast by Type (2022-2027) Table 33. Global Cefotaxime Sodium API Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Cefotaxime Sodium API Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Cefotaxime Sodium API Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 36. Global Cefotaxime Sodium API Sales by Application (2016-2021) (MT) Table 37. Global Cefotaxime Sodium API Sales Share by Application (2016-2021) Table 38. Global Cefotaxime Sodium API Revenue by Application (2016-2021) (US$ Million) Table 39. Global Cefotaxime Sodium API Revenue Share by Application (2016-2021) Table 40. Cefotaxime Sodium API Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 41. Global Cefotaxime Sodium API Sales Forecast by Application (2022-2027) & (MT) Table 42. Global Cefotaxime Sodium API Sales Market Share Forecast by Application (2022-2027) Table 43. Global Cefotaxime Sodium API Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Cefotaxime Sodium API Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Cefotaxime Sodium API Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 46. Japan Cefotaxime Sodium API Sales (MT) of Key Companies (2016-2021) Table 47. Japan Cefotaxime Sodium API Sales Share by Company (2016-2021) Table 48. Japan Cefotaxime Sodium API Revenue (US$ Million) by Company (2016-2021) Table 49. Japan Cefotaxime Sodium API Revenue Share by Company (2016-2021) Table 50. Japan Cefotaxime Sodium API Sales (MT) by Type (2016-2021) Table 51. Japan Cefotaxime Sodium API Sales Share by Type (2016-2021) Table 52. Japan Cefotaxime Sodium API Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. Japan Cefotaxime Sodium API Price (USD/MT) by Type (2016-2021) Table 54. Japan Cefotaxime Sodium API Sales (MT) by Type (2022-2027) Table 55. Japan Cefotaxime Sodium API Sales Share by Type (2022-2027) Table 56. Japan Cefotaxime Sodium API Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. Japan Cefotaxime Sodium API Revenue Share by Type (2022-2027) Table 58. Japan Cefotaxime Sodium API Price (USD/MT) by Type (2022-2027) Table 59. Japan Cefotaxime Sodium API Sales (MT) by Application (2016-2021) Table 60. Japan Cefotaxime Sodium API Sales Share by Application (2016-2021) Table 61. Japan Cefotaxime Sodium API Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. Japan Cefotaxime Sodium API Price (USD/MT) by Application (2016-2021) Table 63. Japan Cefotaxime Sodium API Sales (MT) by Application (2022-2027) Table 64. Japan Cefotaxime Sodium API Sales Share by Application (2022-2027) Table 65. Japan Cefotaxime Sodium API Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. Japan Cefotaxime Sodium API Revenue Share by Application (2022-2027) Table 67. Japan Cefotaxime Sodium API Price (USD/MT) by Application (2022-2027) Table 68. North America Cefotaxime Sodium API Sales by Country (2016-2021) & (MT) Table 69. North America Cefotaxime Sodium API Sales Market Share by Country (2016-2021) Table 70. North America Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Cefotaxime Sodium API Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Cefotaxime Sodium API Sales by Region (2016-2021) & (MT) Table 73. Asia Pacific Cefotaxime Sodium API Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Cefotaxime Sodium API Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Cefotaxime Sodium API Revenue Market Share by Region (2016-2021) Table 76. Europe Cefotaxime Sodium API Sales by Country (2016-2021) & (MT) Table 77. Europe Cefotaxime Sodium API Sales Market Share by Country (2016-2021) Table 78. Europe Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Cefotaxime Sodium API Revenue Market Share by Country (2016-2021) Table 80. Latin America Cefotaxime Sodium API Sales by Country (2016-2021) & (MT) Table 81. Latin America Cefotaxime Sodium API Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Cefotaxime Sodium API Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Cefotaxime Sodium API Sales by Country (2016-2021) & (MT) Table 85. Middle East and Africa Cefotaxime Sodium API Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Cefotaxime Sodium API Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Cefotaxime Sodium API Revenue Market Share by Country (2016-2021) Table 88. REYOUNG Corporation Information Table 89. REYOUNG Description and Business Overview Table 90. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 91. REYOUNG Cefotaxime Sodium API Product Table 92. REYOUNG Recent Development Table 93. Nectar Lifesciences Corporation Information Table 94. Nectar Lifesciences Description and Business Overview Table 95. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Nectar Lifesciences Product Table 97. Nectar Lifesciences Recent Development Table 98. Medya Pharma Corporation Information Table 99. Medya Pharma Description and Business Overview Table 100. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 101. Medya Pharma Product Table 102. Medya Pharma Recent Development Table 103. Sandoz Corporation Information Table 104. Sandoz Description and Business Overview Table 105. Sandoz Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 106. Sandoz Product Table 107. Sandoz Recent Development Table 108. Kelun Corporation Information Table 109. Kelun Description and Business Overview Table 110. Kelun Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 111. Kelun Product Table 112. Kelun Recent Development Table 113. NCPC Corporation Information Table 114. NCPC Description and Business Overview Table 115. NCPC Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 116. NCPC Product Table 117. NCPC Recent Development Table 118. Aurobindo Pharma Corporation Information Table 119. Aurobindo Pharma Description and Business Overview Table 120. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 121. Aurobindo Pharma Product Table 122. Aurobindo Pharma Recent Development Table 123. United Laboratories Corporation Information Table 124. United Laboratories Description and Business Overview Table 125. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 126. United Laboratories Product Table 127. United Laboratories Recent Development Table 128. Orchid Pharma Corporation Information Table 129. Orchid Pharma Description and Business Overview Table 130. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 131. Orchid Pharma Product Table 132. Orchid Pharma Recent Development Table 133. CSPC Corporation Information Table 134. CSPC Description and Business Overview Table 135. CSPC Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 136. CSPC Product Table 137. CSPC Recent Development Table 138. Kopran Corporation Information Table 139. Kopran Description and Business Overview Table 140. Kopran Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 141. Kopran Product Table 142. Kopran Recent Development Table 143. Covalent Corporation Information Table 144. Covalent Description and Business Overview Table 145. Covalent Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 146. Covalent Product Table 147. Covalent Recent Development Table 148. ACS Dobfar Corporation Information Table 149. ACS Dobfar Description and Business Overview Table 150. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 151. ACS Dobfar Product Table 152. ACS Dobfar Recent Development Table 153. Dawnrays Corporation Information Table 154. Dawnrays Description and Business Overview Table 155. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 156. Dawnrays Product Table 157. Dawnrays Recent Development Table 158. Sterile India Corporation Information Table 159. Sterile India Description and Business Overview Table 160. Sterile India Cefotaxime Sodium API Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 161. Sterile India Product Table 162. Sterile India Recent Development Table 163. Cefotaxime Sodium API Market Trends Table 164. Cefotaxime Sodium API Market Drivers Table 165. Cefotaxime Sodium API Market Challenges Table 166. Cefotaxime Sodium API Market Restraints Table 167. Cefotaxime Sodium API Customers List Table 168. Cefotaxime Sodium API Distributors List Table 169. Research Programs/Design for This Report Table 170. Key Data Information from Secondary Sources Table 171. Key Data Information from Primary Sources List of Figures Figure 1. Cefotaxime Sodium API Product Picture Figure 2. Global Cefotaxime Sodium API Sales Market Share by Type in 2020 & 2027 Figure 3. ChP Product Picture Figure 4. USP Product Picture Figure 5. EP Product Picture Figure 6. Global Cefotaxime Sodium API Sales Market Share by Application in 2020 & 2027 Figure 7. Single Injection Figure 8. Compound Injection Figure 9. Cefotaxime Sodium API Report Years Considered Figure 10. Global Cefotaxime Sodium API Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Cefotaxime Sodium API Market Size 2016-2027 (US$ Million) Figure 12. Global Cefotaxime Sodium API Sales 2016-2027 (MT) Figure 13. Global Cefotaxime Sodium API Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Cefotaxime Sodium API Sales Market Share by Region (2016-2021) Figure 15. Global Cefotaxime Sodium API Sales Market Share by Region in 2020 Figure 16. Global Cefotaxime Sodium API Revenue Market Share by Region (2016-2021) Figure 17. Global Cefotaxime Sodium API Revenue Market Share by Region in 2020 Figure 18. Global Cefotaxime Sodium API Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Cefotaxime Sodium API Revenue in 2020 Figure 20. Cefotaxime Sodium API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Cefotaxime Sodium API Sales Market Share by Type (2016-2021) Figure 22. Global Cefotaxime Sodium API Sales Market Share by Type in 2020 Figure 23. Global Cefotaxime Sodium API Revenue Market Share by Type (2016-2021) Figure 24. Global Cefotaxime Sodium API Revenue Market Share by Type in 2020 Figure 25. Global Cefotaxime Sodium API Sales Market Share by Application (2016-2021) Figure 26. Global Cefotaxime Sodium API Sales Market Share by Application in 2020 Figure 27. Global Cefotaxime Sodium API Revenue Market Share by Application (2016-2021) Figure 28. Global Cefotaxime Sodium API Revenue Market Share by Application in 2020 Figure 29. Japan Cefotaxime Sodium API Sales Growth Rate 2016-2027 (MT) Figure 30. Japan Cefotaxime Sodium API Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. Japan Cefotaxime Sodium API Market Share in Global Market 2016-2027 Figure 32. Japan 5 and 10 Largest Cefotaxime Sodium API Players Market Share by Revenue in Cefotaxime Sodium API in 2020 Figure 33. Japan Cefotaxime Sodium API Revenue Share by Type (2016-2021) Figure 34. Japan Cefotaxime Sodium API Revenue Growth Rate by Type in 2016 & 2020 Figure 35. Japan Cefotaxime Sodium API Revenue Share by Application (2016-2021) Figure 36. Japan Cefotaxime Sodium API Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Cefotaxime Sodium API Sales Growth Rate 2016-2021 (MT) Figure 38. North America Cefotaxime Sodium API Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Cefotaxime Sodium API Sales Market Share by Country in 2020 Figure 40. North America Cefotaxime Sodium API Revenue Market Share by Country in 2020 Figure 41. U.S. Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 42. U.S. Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 44. Canada Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Cefotaxime Sodium API Sales Growth Rate 2016-2021 (MT) Figure 46. Europe Cefotaxime Sodium API Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Cefotaxime Sodium API Sales Market Share by Country in 2020 Figure 48. Europe Cefotaxime Sodium API Revenue Market Share by Country in 2020 Figure 49. Germany Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 50. Germany Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 52. France Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 54. U.K. Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 56. Italy Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 58. Russia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Cefotaxime Sodium API Sales Growth Rate 2016-2021 (MT) Figure 60. Asia Pacific Cefotaxime Sodium API Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Cefotaxime Sodium API Sales Market Share by Region in 2020 Figure 62. Asia Pacific Cefotaxime Sodium API Revenue Market Share by Region in 2020 Figure 63. China Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 64. China Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 66. Japan Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 68. South Korea Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 70. India Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 72. Australia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 74. Taiwan Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 76. Indonesia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 78. Thailand Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 80. Malaysia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 82. Philippines Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 84. Vietnam Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Cefotaxime Sodium API Sales Growth Rate 2016-2021 (MT) Figure 86. Latin America Cefotaxime Sodium API Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Cefotaxime Sodium API Sales Market Share by Country in 2020 Figure 88. Latin America Cefotaxime Sodium API Revenue Market Share by Country in 2020 Figure 89. Mexico Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 90. Mexico Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 92. Brazil Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 94. Argentina Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Cefotaxime Sodium API Sales Growth Rate 2016-2021 (MT) Figure 96. Middle East and Africa Cefotaxime Sodium API Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Cefotaxime Sodium API Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Cefotaxime Sodium API Revenue Market Share by Country in 2020 Figure 99. Turkey Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 100. Turkey Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 102. Saudi Arabia Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Cefotaxime Sodium API Sales Growth Rate (2016-2021) (MT) Figure 104. UAE Cefotaxime Sodium API Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Cefotaxime Sodium API Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

REYOUNG Nectar Lifesciences Medya Pharma Sandoz Kelun NCPC Aurobindo Pharma United Laboratories Orchid Pharma CSPC Kopran Covalent ACS Dobfar Dawnrays Sterile India